Date Time Headline
23/02/2018 9:03AM
(Dow Jones) Viralytics Price Target Cut 24% to A$1.75/Share by Bell Potter
(headline only)
BP may know something we don't, in that there is not another offer 'in the winds' perse, then again, perhaps it's just a 'political' exercise to 'realign' their clients/followers to their new 'school of thought' perhaps...
I will certainly be 'unpleasantly' surprised if BMS doesn't make some kind of move, CA21 is worth more to them with it 'demonstrating' a 46% improvements (11%>57%) in combo with Vervoy & CA21, buut the have just committed US$1.8bn to the Nektar partnership, they've got plenty of $$$ though, US$9bn to repatriate after US Tax-Bill from memory...
Wait and see I guess, I'll hold out until any SOA (deal) finalises itself, unless we get a 'very attractive offer' that may influence my thoughts...